We introduce a system with a lyophilic matrix to aid dissolution studies of powders and particulate systems. This lyophilic matrix method (LM method) is based on the ability to discriminate between non-dissolved particles and the dissolved species. In the LM method the test substance is embedded in a thin lyophilic core-shell matrix. This permits rapid contact with the dissolution medium while minimizing dispersion of non-dissolved particles without presenting a substantial diffusion barrier. The method produces realistic dissolution and release results for particulate systems, especially those featuring nanoscale particles. By minimizing method-induced effects on the dissolution profile of nanopowders, the LM method overcomes shortcomings associated with current dissolution tests.
Introduction
The dissolution rate of a drug is a physico-chemical property to be determined and modified during drug discovery and development [1, 2] . For example, reducing the particle size to the nanoscale increases the dissolution rate and thus the bioavailability of poorly water-soluble drugs in classes II and IV of the Biopharmaceutics Classification System [3] [4] [5] . The dissolution rate of nanoscale particles correlates with the performance and quality of a formulation featuring nanoparticles [3] . Hence to assess the impact of nanonizing a poorly water-soluble drug, one needs reliable dissolution rate data of nanoparticulate systems. Such data could allow one to predict realistic in vitro − in vivo (IVIV)-correlation and facilitate determination of dose in animal experiments [6] [7] [8] .
Current methods for investigating dissolution rates of nanoscale particles include the United States Pharmacopoeia (USP) I (basket), II (paddle), and IV (flow-through) methods, as well as modifications thereof, membrane diffusion methods (such as the dialysis methods), and sample and separate methods (such as centrifugal ultrafiltration) [6, 7, [9] [10] [11] [12] [13] [14] . Additionally, dissolution rates of nanoparticles have been determined from tablets and admixtures using gel matrices [15, 16] . Often, the measured values reflect features of the dissolution test device, equipment or method, rather than the nanoparticle properties.
The main issues with the current methods include: dispersion of non-dissolved particles, hydrodynamics-induced variability, membrane effects caused by diffusion barriers (e.g. gelatin, filters, or dialysis membranes), clogging and breaking of filters, sensitivity to flow and location in the dissolution vessel, as well as migration of nanoparticles to interfaces (e.g. wetting issues, floating, or adhesion) [17] [18] [19] [20] [21] [22] [23] [24] . The UPS methods were not designed for dissolution studies of nanoscale particles and thus produce unrealistic results [13, 17] . Dispersion and the consequent overestimation of nanoparticle dissolution rates in the USP I and II methods occur when the location of the particles is not fixed. Dispersion occurs in the USP IV method when a too large filter pore size is used [6] . On the other hand, constraining diffusion of the dissolved species by membranes or encapsulation, leads to measurement of the quality of the diffusion barrier rather than that of the nanoparticle dissolution, and often to underestimating the dissolution rate [17, 19, 25, 26] . Using tablets or admixtures may alter the physical form of the drug during the tableting or mixing, and particles may detach from the tablet surface during the dissolution process, or induce a diffusion barrier [15, 16] . Accordingly, there is a need for new methods and devices for determining dissolution rates of nanoparticles. 
Materials and methods

Chemicals
Indomethacin (Hawkins, USA) was used as poorly water-soluble model compound in the experiments and poloxamer 188 (BASF Co., Germany) was used as stabilizer. The chemicals used for preparing the media for the dissolution studies were monopotassium phosphate (Riedel-de Haën, Germany), sodium phosphate dibasic (Sigma-Aldrich, USA), and 5 M sodium hydroxide (VWR Chemicals BDH Prolabo, EC). All chemicals in the experiments were of analytical grade and were used as received.
Structure of the device
The experimental device comprised a lyophilic matrix, a cage, a vessel, and a mixing/heating plate (Fig. 1) . The matrix has a coreshell structure comprising a core matrix that contained the particles of the test substance, and a surrounding shell matrix. The matrix material of both core and shell matrices is cotton (100% cotton, Curatex GmbH, Germany). The shell matrix consists of four layers of water jet-pressurized cotton with a dry specific surface weight of 5 ± 0.2 mg/cm 2 . Cotton was selected as matrix material due to its unique properties; hollow cellulose fibers, high wet strength, inert nature, and substantial ability to absorb water-based media. The custom designed stainless steel cages (depth 3 mm × height 26 mm × width 16 mm) were 3D printed with selective laser sintering (Mlab Cusing, Concept Labs, Germany). The cage maintained the desired matrix geometry and provided a fixed diffusion distance.
Characterization of the matrix
Matrix-medium interaction
The cotton matrix was examined prior to, during, and after medium exposure with light microscopy (Leica DMLB, Leica Microsystems Wetzlar, Germany) with a magnification of 200×, and prior to, and after medium exposure with scanning electron microscopy (SEM, Quanta TM 250 FEG, FEI Inc., USA) with a magnification of 500×, voltage of 5.00 kV, spot size of 3.0, sputter coated with a 5-nm-thick platinum layer (Q150T Quomm, Beijing, China). The water intake properties of the matrix were investigated with a fast camera (1200 fps, Casio Exilim High-speed EX-FI1, Casio, Japan) and by weighing the matrix prior to and after exposure to the medium.
Drug-matrix interaction
The partitioning of the model compound between the matrix and medium was examined by partition coefficient and inverse partitioning coefficient studies. First, the retention of the model compound within the matrix was examined. This was done by partition coefficient tests, where the matrix containing 1 mg of bulk indomethacin was immersed in the medium, and collected after 22 h. The indomethacin retained in the matrix was determined by immersing the matrix into fresh medium for 22 h. This procedure was conducted with three parallel experiments in pH 5.5 and pH 7.4 phosphate buffer media [27] at 37.0 ± 0.5 • C with a stirring rate of 180 rpm (IKA RT 15 P, IKA Werke GmbH & CO. KG, Germany). The concentration of the medium was determined after the first and the second immersion at the 22 h time point. The concentration of the samples was analyzed with high performance liquid chromatography (HPLC Thermo System Products, Agilent 1200 Infinity Series, Agilent Technologies, Germany), using a Discovery C18 column (4.6 × 150 mm, 5 m, Supelco, USA), 1.5 mL/min flow rate with a mobile phase consisting of 60:40 (V/V) acetonitrile (ACN) and 0.2% ortophosphoric acid (H 3 PO 4 ) in water (MilliQ), operating at 30 • C with detection at 270 nm. The standard curve for indomethacin quantification was acquired from triplicate samples of indomethacin concentrations between 0.08 mg/L and 500 mg/L (R 2 = 0.999).
Second, the partitioning of the dissolved species into the matrix was examined. This was done by inverse partition coefficient tests, where an empty matrix was inserted into medium with saturated concentration of the model compound. The test was conducted in triplicate in phosphate buffer media with pH of 5.5 and 7.4. The empty matrices were inserted into the medium every 5 min and the test lasted 20 min. The concentration of the medium was monitored online using in-situ fiber-optic UV monitoring (Opt-Diss 410, Distek, Inc., USA) using probes with a path-length of 5 mm, exposure time of 44 ms (4 scans/data point) at an analytical wavelength of 320 nm.
Drug release studies 2.4.1. Preparation and characterization of the particles
A nanosized fraction, two sieved particle size fractions, and bulk indomethachin were tested with the LM method. Nanosuspension was prepared by milling with a Fritsch Pulverisette 7 Premium ball mill (Fritsch GmbH, Germany) to obtain particles for the experiments. Nanoparticles for the LM method were prepared of 2 g indomethacin suspended in solution containing 5.0 mL 0.24 g/mL poloxamer 188 solution (60 wt% relative to the drug amount) and 5.0 mL water (milliQ), and by grinding at 850 rpm in 5 cycles of 3 min using 60 g milling pearls (zirconium oxide, diameter 1 mm). The particle size distribution in the nanosuspension was determined with a Zetasizer Nano SZ (Malvern Instruments Ltd., UK).
The bulk indomethacin was divided into two fractions using a sieve with 125 m eye size of (Fritsch GmbH, Germany). The particle size of the bulk powder and the two fractions were determined from SEM images (see Section 2.3.1.) (n = 300, ImageJ freeware, National Institutes of Health, USA). The bulk powder and the two fractions were each mixed with poloxamer 188 (60 wt% relative to the drug amount) to achieve physical mixtures with content identical to the nanosuspension.
Dissolution experiments
The test substances (corresponding to 0.5 mg of indomethacin) were distributed within the core matrix. The indomethacin suspension was introduced into the core matrix by wetting the core cotton evenly with the indomethacin suspension and then drying the core cotton. The dry powder was introduced into the core matrix by carefully mixing the particles with the core cotton in a mortal. The particles were collected into the core matrix as they adhere onto the core cotton fibers. Quantities corresponding to 3 mg of core cotton and 0.5 mg of indomethacin were weighed and the core cotton was placed between the shell matrices. The core cotton was distributed between the shell matrices as a square shaped even layer. The core matrix had a slightly smaller surface area than shell matrices to have the core matrix covered with the shell matrices from all sides. The matrix was then placed in the stainless steel cage acting as the matrix holder. Dissolution tests were conducted in triplicate for nanoparticles, bulk powder, and the two particle size fractions in pH 5.5 phosphate buffer medium [27] and for nanoparticles and bulk powder in pH 7.4 phosphate buffer medium [27] . All tests were performed in 100 mL of dissolution medium at 37.0 ± 0.5 • C using a stirring rate of 180 rpm (IKA RT 15 P, IKA Werke GmbH & CO. KG, Germany). The dissolution medium outside the matrix provided sink conditions. The stirring rate and the matrix geometry were optimized with preliminary experiments. Aliquots of 1 mL, subsequently replaced with the same volume of fresh medium, were taken at 12 time points: 30 s, 1 min, 2 min, 5 min, 10 min, 30 min, 1 h, 2 h, 3 h, 4 h, 6 h, and 22 h. The samples were analyzed with HPLC as described in section 2.3.2. Cumulative release of indomethacin and standard deviation in three parallel samples were determined for each experiment. Additionally, the dissolution medium of pH 5.5 was examined with dynamic light scattering (Zetasizer Nano ZS, Mal-vern Instruments Ltd., UK) immediately after withdrawal at time points of 1 min, 2 min, and 5 min.
Results and discussion
Properties of the matrix
Matrix-medium interaction
No visual changes were detected in the size, topology, and morphology of the cotton fibers as the matrix was exposed to dissolution medium, nor did the structure of the cotton change after drying (Fig. 2) . When immersed into medium, the cotton matrix was wetted in 0.31 s ± 0.10 s. The matrix withdrew medium approximately 23 times its weight. The matrix volume increases when exposed to medium. However, microscope studies indicated that the single fibers do not swell when immersed into the medium.
Drug-matrix interaction
No retained indomethacin was found in the matrix at 22 h in the partition coefficient tests. The concentrations obtained were below the detection limit (0.08 mg/L) of the HPLC method. This indicates that >99.2% of indomethacin is released from the matrix and that the dissolved species is not significantly retained within the matrix. The inverse partition coefficient test showed no detectable change in concentration when the matrix was immersed into the medium with dissolved indomethacin. Based on the detection limit of the online measurement device, the possible undetected change in the concentration is <2.3%. This indicates that >97.7% of the dissolved species is not affected by the immersion of the matrix and that the matrix does not significantly absorb dissolved indomethacin from the dissolution medium.
As shown in the characterization tests, the matrix is practically inert and has little effect on the total quantity of indomethacin released and the particles within the matrix are exposed to the medium immediately after immersion ( Table 1) . As the pH has no effect on the partition coefficient, we conclude that at least with indomethacin − a weak acid (pK a 4.5) − the change in the pH of the medium causes no adsorption onto the fibers. The partitioning coefficient studies were conducted only in regard to the dissolved species. The possible adhesion is not considered to be an issue, since the non-dissolved particles should remain within the matrix. 
Dissolution rate
Differences in dissolution rate as function of particle size and pH were evident in the dissolution profiles obtained with the LM method. Fig. 3 shows the cumulative release of indomethacin nanoparticles, small and large size fraction in pH 5.5, and nanoparticles and bulk indomethacin in pH 7.4 up to 30 min. The short lag times of less than 1 min indicated rapid wetting of the samples and absence of any significant membrane effect caused by diffusion barrier. Monotonously increasing dissolution profiles and constant standard deviations indicate that the variation between aliquots is moderate, i.e. that no substantial withdrawal of particles occurred during sampling. The method was accurate with small sample quantities and differences between the dissolution rates were detected within 5 min from the start of the experiment as seen in the dissolution profiles. Particles from the matrix are not released to such extent that there would be a detectable difference between plain medium and medium withdrawn during the dissolution experiment at time points of 1 min, 2 min, and 5 min. The release of particles from the matrix is not completely excluded, however, it is not significant enough to be detected with dynamic light scattering, in withdrawn samples analyzed by HPLC, or as disruption the differentiation of dissolution rates of different particle sizes. 
Principle of the LM method
The key factor of the LM method is its ability to separate non-dissolved particles from dissolved species and its ability to prevent dispersion of the particulates without presenting a significant membrane effect. The dissolved species exit the matrix, whereas the non-dissolved particles remain within the matrix (Fig. 4) .
Instead of dispersing the particles into the dissolution medium or exchanging the medium through a barrier, the matrix fixes the position of the non-dissolved particles and brings the medium to the particles. In the LM method the particles are dissolved from a stationary point in a semi 2-dimensional system under sink conditions. The efficient intake of medium, the concentration gradient, and the mild convection induced in the vessel drive the dissolved species out of the matrix. The matrix forms no separate compartment in the dissolution vessel, as for example a dialysis bag does, and the lack of interaction between the cotton fibers and the model compound ensures that the dissolved species is not trapped in the matrix. Microenvironments around the dissolving particles are likely to exist, as in any dissolution system, yet combined with mild convection, the system provides fresh medium into the matrix. The quantity and the geometry of the matrix were chosen to be such that these allowed rapid wetting and thus quick exchange of the medium within the matrix. No sudden changes in the dissolution rates were observed indicating that there were no disruptions in the dissolution process of the particles.
The dissolution of the particles within the matrix is initiated as the matrix absorbs medium. The whole particle population is wetted nearly simultaneously. The dissolution rate depends on the active surface area of the particles as described by the NernstBrunner equation and the radius and particle curvature as described by the Gibbs-Kelvin equation [28] [29] [30] . The equations predict that small particles dissolve faster than large ones.
Results produced by the LM method do neither overestimate the dissolution rates due to dispersion of particles nor do they induce substantial lag times. The ability to produce realistic dissolution data supports early formulation development, which is valuable for evaluation of advantages gained by particle size reduction. Small sample-to-sample variation produces reliable results with small inter-or intra-laboratory variation. Consequently, dissolution testing with lyophilic matrices produces realistic estimates of dissolution rates of nanoscale particles. Further studies are needed to prove the universal applicability of the LM method and to assess the dissolution rate for different substances as well as to verify the IVIV-correlation. The method requires testing especially with soft particle systems, since the matrix-particle −interaction with these systems may be significantly different to that of powders.
Conclusions
The lyophilic matrix method developed in this study is suitable for determining dissolution rates of particulate systems, especially of nanoscale particles. The method features short lag time, small sample-to-sample variation, and monotonously increasing dissolution profiles. The method discriminated between the dissolution rates of the tested particle size fractions. The inert cotton matrix permitted release studies without substantial diffusion barrier, it avoided dispersion of the non-dissolved particles, and rapidly wetted the sample.
